This is a non-core endpoint: only basic statistics are computed.
Myopathy due to other toxic agents
G6_MYOPTOX
muscular disease: Acquired, familial, and congenital disorders of skeletal muscle and smooth muscle.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
17 |
4. Check minimum number of eventsNone |
17 |
5. Include endpointsNone |
17 |
6. Filter based on genotype QC (FinnGen only) |
16 |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Myopathy due to other toxic agents based on the number of shared cases.
Similar with more cases:
- Diseases of the myoneural junction and muscle
- Neurological diseases
- Neurological diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 243 | 92 | 150 |
Only index persons | 196 | 81 | 115 |
Unadjusted period prevalence (%) | |||
Whole population | 0.00 | 0.00 | 0.00 |
Only index persons | 0.00 | 0.00 | 0.00 |
Median age at first event (years) | |||
Whole population | 63.76 | 68.85 | 60.64 |
Only index persons | 63.00 | 68.10 | 59.40 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 16 | 6 | 10 |
Unadjusted period prevalence (%) | 0.00 | 0.00 | 0.01 |
Median age at first event (years) | 60.22 | 64.20 | 57.83 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
Mortality – FinRegistry
↥Association
Association between endpoint G6_MYOPTOX and mortality.
Females
No dataMales
Parameter | HR [95% CI] | p-value |
---|---|---|
G6_MYOPTOX | 4.005 [1.69, 9.49] | 0.002 |
Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 70 out of 129 males with G6_MYOPTOX died.
Mortality risk
Mortality risk for people of age
years, who have G6_MYOPTOX.N-year risk | Females | Males |
---|---|---|
1 | No data | 0.809% |
5 | No data | 4.477% |
10 | No data | 11.36% |
15 | No data | 21.072% |
20 | No data | 33.822% |
Relationships between endpoints
↥Index endpoint: G6_MYOPTOX – Myopathy due to other toxic agents
GWS hits: -